Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Protalix Biotherapeutics Inc (PLX.TA)

PLX.TA on Tel Aviv Stock Exchange

250.50
30 Jun 2016
Change (% chg)

-1.20₪ (-0.47%)
Prev Close
254.40₪
Open
254.40₪
Day's High
259.00₪
Day's Low
250.30₪
Volume
88,538
Avg. Vol
71,180
52-wk High
759.00₪
52-wk Low
250.30₪

Bronfeld, Zeev 

Mr. Zeev Bronfeld has been appointed as an Independent Director of Protalix Biotherapeutics, Inc. effective July 24, 2014. From 2010 through July 2014, he served as the interim Chairman of our Board of Directors. Mr. Bronfeld brings to us vast experience in management and value building of biotechnology companies. Mr. Bronfeld is an experienced businessman who is involved in a number of biotechnology companies. He is a co-founder of Biocell Ltd. (TASE:BCEL), an Israeli publicly traded holding company specializing in biotechnology companies, and has served as its Chief Executive Officer since 1986. Mr. Bronfeld currently serves as a director of Biocell Ltd. and Macrocure Ltd. (NASDAQ: MCUR) and the as chairman of the board of directors of D.N.A. Biomedical Solutions Ltd. (TASE:DNA), all of which are public companies. Mr. Bronfeld is also a director of a number of privately-held companies, most of which are involved in the life sciences, such as The Trendlines Group, Contipi Medical Ltd. and TransBiodiesel Ltd. From 2004 through 2012, Mr. Bronfeld served as a director of D. Medical Industries Ltd., a company that was dually-listed on the Nasdaq and the TASE. Mr. Bronfeld received a B.A. in Economics from the Hebrew University in 1975.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Shlomo Yanai

--

Moshe Manor

205,733

Yossi Maimon

859,997

Tzvi Palash

482,763

Yoseph Shaaltiel

775,897

Einat Almon

678,820
As Of  30 Dec 2014